Associate Investigator, Neurology, Massachusetts General Research Institute; Associate Professor of Neurology, Harvard Medical School
Dora Kovacs always had a passion for science. Born in Budapest, Hungary, Kovacs’ mother was an entomologist who introduced her to the world of science. At age 16, a friend invited her to England for a summer internship where she felt “lucky to be growing bacteria.”
Years later, her Ph.D. studies of the expression of the amyloid precursor protein (APP) gene in the central nervous system led to a breakthrough paper she co-authored in 1988 with Rudy Tanzi, Ph.D.
Dr. Kovacs has been recognized for her discovery of a novel strategy for modifying amyloid beta generation via the cholesterol esteriﬁcation pathway—the formation of insoluble cholesterol-esters from cholesterol and fatty acids—in her ﬁrst research project funded by Cure Alzheimer’s Fund.
Kovacs and Tanzi are still focused on their shared passion for ﬁnding a cure for Alzheimer’s disease.
“Because NIH only covers part of my research expenses, funding from Cure Alzheimer’s Fund was essential to my work.”
To learn more about the Kovacs Lab, click here.